// App-Quantinova.ai

P016 : GI restricted ROCK inhibitors show potential to treat fibrosis and stenosis associated with inflammatory bowel disease

Researchers

Presenter

  • C Jones

Principal Investigators

  • K Eckersley

  • N Hawkins

  • R Armer

  • M Bingham

  • C Phillips

  • T Holvoet

  • S Devriese

  • K Castermans

  • S Boland

  • D Leysen

  • Y -P Vandewynckel

  • L Devisscher

  • L Van den Bossche

  • S Van Welden

  • M Dullaers

  • R Vandenbroucke

  • R De Rycke

  • K Geboes

  • A Bourin

  • O Defert

  • P Hindryckx

  • M De Vos

  • D Laukens

Medical Centers

  • Redx Pharma, Alderley Park, UK

  • Ghent University Hospital, Department of Gastroenterology, Ghent, Belgium

  • Amakem Therapeutics, Diepenbeek, Belgium

  • Inflammation Research Centre, VIB, Ghent, Belgium

  • Ghent University, Internal Medicine, Ghent, Belgium

  • Gent University, Biology, Gent, Belgium

Locations

  • United Kingdom

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • N/A

Biomarkers

  • Cluster of Differentiation 4

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved